A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

The combination of tenofovir, FTC, and efavirenz might soon be available in a single pill. For years, effective antiretroviral treatment has required HIV-positive patients to take a large handful ...

A new study by UCSF researchers reveals that long-acting injectable treatments offer a promising alternative for HIV patients who find it challenging to adhere to daily pill regimens. This ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found. The strategy could also help stop the spread ...

The triple-combination of bictegravir, emtricitabine, and tenofovir alafenamide is a one-a-day pill to treat patients with HIV-1.

A digital pill that records when it is taken has been ... treatment used to protect them from contracting HIV. A pilot study, which involved 16 men who have sex with men (MSM) and a history ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UCSF has found. The strategy could also help stop the spread of HIV ...